Hypovase 1mg Tablets
27mm
Throughout this leaflet this product will be collectively referred to as Hypovase.
Read all of this leaflet carefully before you start taking this medicine.
• Keep this leaflet. You may need to read it again.
• If you have any further questions, ask your doctor or pharmacist.
• This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours.
• If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
![](/data/mhra/doc/102619cb426443ddabc2df4f3860ec55_files/102619cb426443ddabc2df4f3860ec55-1.png)
In this leaflet:
1. What Hypovase is and what it is used for
2. Before you take Hypovase
3. How to take Hypovase
4. Possible side effects
5. How to store Hypovase
6. Further information
DC
< s-
<N UJ
bQ
< U)
Q O
So
<Z
Q I--J £
n P
1. What Hypovase is and what it is used for
Hypovase is one of a group of medicines called alpha-blockers.
It is usually used to treat high blood pressure (hypertension). It may also be used to treat heart failure, painful cold fingers (Raynaud's Disease) or mild enlargement of the prostate gland (prostatic hyperplasia) in men.
In patients with high blood pressure (hypertension) Hypovase works by relaxing blood vessels so that blood passes through them more easily. It can be used alone or in combination with other drugs used to treat hypertension.
In patients with heart failure, Hypovase works by relaxing the main blood vessels of the heart, allowing the heart to pump blood more easily. Hypovase is usually used in heart failure when other drugs are either no longer working or have not worked at all.
In patients with Raynaud's Disease the treatment relaxes blood vessels in the hands, so blood can reach the fingers more easily. This helps to prevent coldness and stiffness.
In patients with enlargement of the prostate gland the treatment is taken to treat poor and/or frequent passing of urine. This is common in patients with enlargement of the prostate gland.
The treatment works by relaxing muscle around the bladder and prostate gland so urine is passed more easily.
You should ask your doctor if you are unsure why you have been given Hypovase.
2. Before you take Hypovase
Do not take Hypovase if you:
• are allergic (hypersensitive) to prazosin, or to any similar drugs (known as quinazoline drugs) or any of the other ingredients listed in section 6. This may have caused itching, reddening of the skin or difficulty in breathing.
• are under 12 years of age.
Take special care with Hypovase
Medicines are not always suitable for everyone. Your doctor needs to know before you take Hypovase if any of the following apply to you:
• you have heart failure because of another heart condition, e.g. heart valve disease, or a recent heart attack. If you have heart failure, Hypovase can gradually become less helpful over several months. If this happens you may notice swelling of your legs or ankles due to retention of fluid.
This is called 'oedema'. If you develop oedema or weight gain tell your doctor as your doctor may need to change the dose of Hypovase or other medicines you are taking.
• you have ever fainted after passing urine.
• you have liver or kidney disease.
• you are undergoing eye surgery because of a cataract (cloudiness of the lens). This is because Hypovase may cause complications during the surgery which can be managed if your specialist is prepared in advance. Please inform your eye specialist before the operation that you are using or have previously used Hypovase.
Remember to tell your doctor that you are taking Hypovase if you have any tests, such as a urine test, as Hypovase may affect the result.
Taking other medicines
Some medicines can affect the way Hypovase works. If you are taking any of the following medicines tell your doctor before you start the treatment:
• calcium antagonists, ACE inhibitors or beta-blockers which are usually given to treat angina and/or high blood pressure.
• medicines for erectile dysfunction (impotence).
Some patients who take Hypovase for the treatment of high blood pressure or prostate enlargement may experience dizziness or light-headedness, which may be caused by low blood pressure upon sitting or standing up quickly. Certain patients have experienced these symptoms when taking drugs for erectile dysfunction (impotence) with Hypovase. In order to reduce the likelihood that these symptoms occur, you should be on a regular daily dose of Hypovase before you start drugs for erectile dysfunction.
Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.
Taking Hypovase with food and drink
Hypovase can be taken before or after food and drinks.
Pregnancy and Breast-feeding
If you are pregnant, planning to get pregnant or are breast-feeding, tell your doctor before you take Hypovase.
Ask your doctor or pharmacist for advice before taking any medicine.
Driving and using machines
Hypovase may cause dizziness, drowsiness or weakness. If you experience these symptoms, do not drive or use any tools or machinery.
![](/data/mhra/doc/102619cb426443ddabc2df4f3860ec55_files/102619cb426443ddabc2df4f3860ec55-2.png)
3. How to take Hypovase
Always take Hypovase exactly as you doctor has told you. You should check with your doctor or pharmacist if you are not sure.
Hypovase tablets are to be taken by mouth.
Sometimes Hypovase can make you feel light-headed or weak particularly when you first take it.
This can happen when standing up and can occasionally cause fainting. If the treatment makes you feel light-headed or weak; lie down until you feel better. Get up slowly when you feel better.
If you are concerned, tell your doctor.
Hypovase is usually started at the lowest possible dose and gradually increased, depending on how you respond to treatment. Do not change the dose or stop taking the tablets without first checking with your doctor. Make sure you get a new prescription before your tablets run out.
High blood pressure (hypertension)
The recommended starting dose is one 0.5 mg tablet, two or three times a day for 3 to 7 days with the starting dose taken in the evening.
The dose is usually then increased to a 1 mg tablet taken two or three times a day for a further 3 to 7 days. Your doctor may then advise you to gradually increase the dose further (up to a maximum of 20 mg daily) depending on how your blood pressure has responded to treatment.
You will find more about HYPOVASE on the back of this leaflet
![](/data/mhra/doc/102619cb426443ddabc2df4f3860ec55_files/102619cb426443ddabc2df4f3860ec55-3.jpg)
WARNING! WE CANNOT ACCEPT RESPONSIBILITY FOR ANY ERRORS IN THIS PROOF AFTER APPROVAL. THE ARTWORK RECEIVED HAS BEEN SIGNIFICANTLY WARNING! THE COLOURS SHOWN ON THIS PROOF ARE FOR GENERAL REPRESENTATION PURPOSES ONLY. THEY ARE NOT ACCURATE AND MUST NOT
ADJUSTED, REVISED OR RESET BY US FROM DISK OR HARD COPY. WHILST WE TAKE EXTREME CARE AT ALL TIMES TO ENSURE ACCURACY, THE FINAL RESPONSIBILITY USED AS A COLOUR MATCH FOR THE FINISHED JOB. PLEASE REFER TO THE PANTONE COLOUR GUIDES FOR ACCURATE COLOUR REFERENCES.
MUST BETAKEN BY OUR CUSTOMER. IF YOU SIGN THIS PROOF YOU ARE SIGNIFYING FULL APPROVAL OF DESIGN AND TEXT.
O o
O'
3 Q O O -j H
iuOrta
““So
_i _i o fc;
< < 9 m
0! D£ D£ D£
< < a u
CM UJ < <0
a o ^ CD <Z
Q I-_l £ S' P
Heart failure
The recommended starting dose is one 0.5 mg tablet taken two, three or four times a day.
Your doctor may then advise you to increase the dose further (up to a maximum of 20 mg daily) depending on how you have responded to treatment.
Raynaud's disease
The recommended starting dose is one 0.5 mg tablet, twice a day for 3 to 7 days.
Your doctor may then advise you to increase the dose further (up to 2 mg twice a day) depending on how you have responded to treatment.
Enlarged prostate
The recommended starting dose is one 0.5 mg tablet, twice a day for 3 to 7 days, with the initial dose taken in the evening. Your doctor may then advise you to increase the dose further (up to 2 mg twice a day) depending on how you have responded to treatment.
If you take more Hypovase than you should
If you accidentally take too much Hypovase, contact your doctor immediately or go to your nearest hospital casualty department. Always take the labelled medicine package with you, whether there is any Hypovase left or not.
If you forget to take Hypovase
If you forget to take a dose, take it as soon as you remember unless it is time for your next dose. Do not take a double dose to make up for a missed dose.
If you stop taking Hypovase
Do not stop taking Hypovase unless your doctor tells you to. Your condition may return if you stop using Hypovase.
If you have any further questions on how to take this product, ask your doctor or pharmacist.
4. Possible side effects
Hypovase, like most medicines may cause side effects, but not everybody gets them.
Tell your doctor immediately if you experience any of the following symptoms after taking this medicine. Although they are very rare, the symptoms can be severe:
• Sudden wheeziness, difficulty in breathing, swelling of eyelids, face or lips, rash or itching (especially affecting the whole body).
The following side effects have been reported with Hypovase:
Common side-effects (occurring in less than 1 in 10 patients):
• feeling faint, fainting or feeling dizzy, particularly on standing-up (see section 3 ‘How to take Hypovase')
• headache, drowsiness or weakness
• unpleasant sensation of forceful beating of the heart (palpitations)
• feeling or being sick
• lack of energy, depression or nervousness
• constipation or diarrhoea
• dry mouth, nasal stuffiness or blurred vision
• shortness of breath or rash
• swelling of the feet, ankles or legs
• increase in frequency of passing urine
If any of these cause you problems or if they last for more than one week, you should contact your doctor. Other side effects that have been reported are listed below:
Uncommon side-effects (occurring in less than 1 in 100 patients)
• stomach discomfort and/or pain
• chest pain or abnormally fast heart beat
• tingling sensation or numbness
• buzzing or ringing in the ear
• nose bleeds, eye pain or red eyes
• difficulty sleeping
• sweating, itching or itchy skin rash
• painful joints
• inability or difficulty in achieving erection of the penis
Rare side-effects (occurring in less than 1 in 1000 patients)
• abnormal blood tests that check for liver function
• pain or infection in the pancreas
• abnormally slow heartbeat
• hallucinations (imagining things which are not really there)
• hair loss
• low blood pressure
• flushing (redness)
• positive ANA (a blood test that checks function of the immune system)
• abnormal breast tissue development, especially in men
• persistent erection of the penis
• an increased tendency to fall asleep if you have a sleep disorder (narcolepsy)
• leaking of urine (incontinence)
• fever or pain
• inflammation of blood vessels
If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard.
By reporting side effects you can help provide more information on the safety of this medicine.
5. How to store Hypovase
• Do not store Hypovase tablets/Prazosin tablets above 30°C. Store in the original package in a dry place. The expiry date refers to the last day of that month.
• Do not use after the expiry date printed on the carton label or blister strip.
• KEEP ALL MEDICINES OUT OF THE SIGHT AND REACH OF CHILDREN.
• If your doctor tells you to stop taking the tablets, please take them back to the pharmacist for safe disposal. Only keep the tablets if your doctor tells you to.
• The tablets should be whole to work effectively, however if you notice any defects (such as broken tablets) consult your doctor or pharmacist immediately.
• If the tablets become discoloured or show any other signs of deterioration, you should seek the advice of your pharmacist.
• Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.
6. Further information
Each Hypovase 1mg tablet/Prazosin 1mg tablet contains 1mg of the active ingredient, prazosin (as the hydrochloride) in a white, oblong tablet which is marked ‘M' breakline ‘6' on one side and a breakline on the reverse.
Hypovase 1mg tablets/Prazosin 1mg tablets also contain the following:
maize starch, microcrystalline cellulose, calcium phosphate dibasic anhydrous, magnesium stearate, and sodium lauryl sulphate.
Hypovase 1mg tablets/Prazosin 1mg tablets are available in blister packs of 30 and 60 tablets.
POM PL No: 18799/2720 Hypovase 1mg tablets/Prazosin 1mg tablets
This product is manufactured by Farmasierra Manufacturing, S.L., Ctra. N-1, km 26,200-28700 San Sebastian de los Reyes (Madrid), Spain and procured from within the EU and repackaged by the Product Licence holder:
B&S Healthcare, Unit 4, Bradfield Road, Ruislip, Middlesex, HA4 0NU, UK.
Leaflet revision and issue date (Ref.)
Hypovase® is a registered trademark of Pfizer limited.
J
![](/data/mhra/doc/102619cb426443ddabc2df4f3860ec55_files/102619cb426443ddabc2df4f3860ec55-4.jpg)
![](/data/mhra/doc/102619cb426443ddabc2df4f3860ec55_files/102619cb426443ddabc2df4f3860ec55-5.png)
WARNING! WE CANNOT ACCEPT RESPONSIBILITY FOR ANY ERRORS IN THIS PROOF AFTER APPROVAL. THE ARTWORK RECEIVED HAS BEEN SIGNIFICANTLY WARNING! THE COLOURS SHOWN ON THIS PROOF ARE FOR GENERAL REPRESENTATION PURPOSES ONLY. THEY ARE NOT ACCURATE AND MUST NOT
ADJUSTED, REVISED OR RESET BY US FROM DISK OR HARD COPY. WHILST WE TAKE EXTREME CARE AT ALL TIMES TO ENSURE ACCURACY, THE FINAL RESPONSIBILITY USED AS A COLOUR MATCH FOR THE FINISHED JOB. PLEASE REFER TO THE PANTONE COLOUR GUIDES FOR ACCURATE COLOUR REFERENCES.
MUST BETAKEN BY OUR CUSTOMER. IF YOU SIGN THIS PROOF YOU ARE SIGNIFYING FULL APPROVAL OF DESIGN AND TEXT.
![](/data/mhra/doc/102619cb426443ddabc2df4f3860ec55_files/102619cb426443ddabc2df4f3860ec55-6.png)